Overview
Background
Dr Mollee practices as a consultant haematologist in clinical and laboratory haematology at the Princess Alexandra Hospital and is Associate Professor with the University of Queensland Medical School.
Having trained in Brisbane and Toronto, Dr Mollee has developed an international reputation studying amyloidosis and the plasma cell dyscrasias. He holds appointments with the Medical Scientific Advisory Group of Myeloma Australia, Australian Amyloidosis Network, National Blood Cancer Taskforce and is a member of the AACB Monoclonal Gammopathy Working Group and the International Kidney & Monoclonal Gammopathy Research Group. He is a past Chairman of the Australasian Leukaemia and Lymphoma Group (ALLG) and current Chair of the Australian Amyloidosis Network. He heads the Myeloma Service as well as the Queensland Amyloidosis Centre which runs one of the few clinics in Australia dedicated exclusively to the care of patients with amyloidosis.
Availability
- Associate Professor Peter Mollee is:
- Available for supervision
Qualifications
- Masters (Coursework) of Medical Science, University of Newcastle
- Royal Australasian College of Physicians, Royal Australasian College of Physicians
- Royal College of Pathologists of Australasia, Royal College of Pathologists of Australasia
Research impacts
The research of the Queensland Amyloidosis Centre aims to improved the diagnosis, monitoring and therapy of all types of amyloidosis. The Centre, in collaboration with Pathology Queensland and the Translational Research Institute, developed laser capture macrodisscution and tandem mass spectrometry analysis to accurately diagnosis the type of amyloidosis that patients have and have introuduced this assay into the clinical laboratory. Research to improve the diagnosis and monitoring of this rare disease has also assessed immunoglobulin free light chain assays, bone scintigraphy and novel radionuclide PET tracers. The Queensland Amyloidosis Centre maintains an active clinical trial program in amyloidosis therapies including both investigator-initiated and commercial studies.
Works
Search Professor Peter Mollee’s works on UQ eSpace
2015
Journal Article
Treatment of patients with multiple myeloma who are not eligible for stem cell transplantation: Position statement of the myeloma foundation of Australia Medical and Scientific Advisory Group
Quach, H., Joshua, D., Ho, J., Szer, J., Spencer, A., Harrison, S., Mollee, P., Roberts, A. W., Horvath, N., Talaulikar, D., To, B., Zannettino, A., Brown, R., Catley, L., Augustson, B., Jaksic, W., Gibson, J. and Prince, H. M. (2015). Treatment of patients with multiple myeloma who are not eligible for stem cell transplantation: Position statement of the myeloma foundation of Australia Medical and Scientific Advisory Group. Internal Medicine Journal, 45 (3), 335-343. doi: 10.1111/imj.12688
2015
Conference Publication
Diagnosis of Amyloidosis Subtype By Laser-Capture Microdissection (LCM) and Tandem Mass Spectrometry (MS/MS) Proteomic Analysis
Mollee, Peter, Renaut, Patricia, Boros, Samuel, Loo, Dorothy and Hill, Michelle (2015). Diagnosis of Amyloidosis Subtype By Laser-Capture Microdissection (LCM) and Tandem Mass Spectrometry (MS/MS) Proteomic Analysis. 57th Annual Meeting of the American-Society-of-Hematology, Orlando, FL United States, 5-8 December 2015. Washington, DC United States: American Society of Hematology.
2015
Conference Publication
Cardiac amyloid imaging with 18F-florbetaben positron emission tomography: a pilot study
Mollee, P., Law, W. Phillip, Wang, W. Y. S, Moore, P. T. and Ng, A. C. T (2015). Cardiac amyloid imaging with 18F-florbetaben positron emission tomography: a pilot study. International Myeloma Workshop, Rome, Italy, 23-26 September 2015. New York, NY United States: Elsevier. doi: 10.1016/j.clml.2015.07.416
2015
Journal Article
Treatment of patients with multiple myeloma who are eligible for stem cell transplantation: position statement of the Myeloma Foundation of Australia Medical and Scientific Advisory Group
Quach, H., Joshua, D., Ho, J., Szer, J., Spencer, A., Harrison, S. J., Mollee, P., Roberts, A. W., Horvath, N., Talulikar, D., To, B., Zannettino, A., Brown, R., Catley, L., Augustson, B., Jaksic, W., Gibsonm J. and Prince, H. M. (2015). Treatment of patients with multiple myeloma who are eligible for stem cell transplantation: position statement of the Myeloma Foundation of Australia Medical and Scientific Advisory Group. Internal Medicine Journal, 45 (1), 94-105. doi: 10.1111/imj.12640
2015
Journal Article
Intravenous oxycontin-associated thrombotic microangiopathy treated successfully without plasma exchange
Tate, Courtney and Mollee, Peter (2015). Intravenous oxycontin-associated thrombotic microangiopathy treated successfully without plasma exchange. Medical Journal of Australia, 202 (6), 330-332. doi: 10.5694/mja14.01125
2015
Conference Publication
Emergence of Fc gamma RIIb-dominance contributes to resistance to therapeutic antibodies in chronic lymphocytic leukemia patients
Burgess, Melinda, Gill, Devinder, Mapp, Sally, Ellis, Jonathan, Cheung, Catherine, Chambers, Lynne, Mattarollo, Stephen, Mollee, Peter and Saunders, Nicholas (2015). Emergence of Fc gamma RIIb-dominance contributes to resistance to therapeutic antibodies in chronic lymphocytic leukemia patients. XVI International Workshop on Chronic Lymphocytic Leukaemia 2015, Sydney, NSW, Australia, 6–9 September 2015. Abingdon, Oxfordshire, United Kingdom: Taylor & Francis.
2014
Journal Article
Lenalidomide and dexamethasone in transplant-ineligible patients with myeloma
Benboubker, Lotfi, Dimopoulos, Meletios A, Dispenzieri, Angela, Catalano, John, Belch, Andrew R, Cavo, Michele, Pinto, Antonello, Weisel, Katja, Ludwig, Heinz, Bahlis, Nizar, Banos, Anne, Tiab, Mourad, Delforge, Michel, Cavenagh, Jamie, Geraldes, Catarina, Lee, Je-Jung, Chen, Christine, Oriol, Albert, de la Rubia, Javier, Qiu, Lugui, White, Darrell J, Binder, Daniel, Anderson, Kenneth, Fermand, Jean-Paul, Moreau, Philippe, Attal, Michel, Knight, Robert, Chen, Guang, Van Oostendorp, Jason ... Mollee, Peter (2014). Lenalidomide and dexamethasone in transplant-ineligible patients with myeloma. The New England Journal of Medicine, 371 (10), 906-17. doi: 10.1056/NEJMoa1402551
2014
Journal Article
Intensive chemotherapy and reduced-intensity allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia in elderly patients
Jackson, Kathryn, Kennedy, Glen, Mollee, Peter, Marlton, Paula and Morris, Kirk (2014). Intensive chemotherapy and reduced-intensity allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia in elderly patients. Asia-Pacific Journal of Clinical Oncology, 10 (3), 246-254. doi: 10.1111/ajco.12188
2014
Journal Article
Successful treatment of iatrogenic multicentric castleman's disease arising due to recrudescence of HHV-8 in a liver transplant patient
Speicher, D. J., Sehu, M. M., Mollee, P., Shen, L., Johnson, N. W. and Faoagali, J. L. (2014). Successful treatment of iatrogenic multicentric castleman's disease arising due to recrudescence of HHV-8 in a liver transplant patient. American Journal of Transplantation, 14 (5), 1207-1213. doi: 10.1111/ajt.12693
2014
Journal Article
Dual epigenetic targeting with panobinostat and azacitidine in acute myeloid leukemia and high-risk myelodysplastic syndrome
Tan, P., Wei, A., Mithraprabhu, S., Cummings, N., Liu, H. B., Perugini, M., Reed, K., Avery, S., Patil, S., Walker, P., Mollee, P., Grigg, A., D'Andrea, R., Dear, A. and Spencer, A. (2014). Dual epigenetic targeting with panobinostat and azacitidine in acute myeloid leukemia and high-risk myelodysplastic syndrome. Blood Cancer Journal, 4 (1) e170, e170-e170. doi: 10.1038/bcj.2013.68
2014
Journal Article
How to diagnose amyloidosis
Mollee, P., Renaut, P., Gottlieb, D. and Goodman, H. (2014). How to diagnose amyloidosis. Internal Medicine Journal, 44 (1), 7-17. doi: 10.1111/imj.12288
2014
Conference Publication
New diagnostic strategies for assessment of amyloidosis and myeloma
Mollee, Peter (2014). New diagnostic strategies for assessment of amyloidosis and myeloma. 48th Annual Scientific Meeting of the Australasian Division of the IAP, Brisbane, QLD Australia, 31 May – 2 June 2024. Oxford, United Kingdom: Elsevier. doi: 10.1097/01.pat.0000443473.89668.b2
2014
Journal Article
Prognostic value of ZAP-70 expression in chronic lymphocytic leukemia as assessed by quantitative polymerase chain reaction and flow cytometry
Adams, Rebecca L. C., Cheung, Catherine, Banh, Raymond, Saal, Russell, Cross, Donna, Gill, Devinder, Self, Marlene, Klein, Kerenaftali and Mollee, Peter (2014). Prognostic value of ZAP-70 expression in chronic lymphocytic leukemia as assessed by quantitative polymerase chain reaction and flow cytometry. Cytometry Part B - Clinical Cytometry, 86 (2), 80-90. doi: 10.1002/cyto.b.21138
2014
Conference Publication
Recommendations for Serum Free Light Chains (Sflc) Measurement in Routine Laboratories
Tate, Jill, Jovanovich, Sue, Mollee, Peter, Chiu, Weldon, Wienholt, Louise, Gillis, David, Reibelt, Lindsay and Youdell, Odette (2014). Recommendations for Serum Free Light Chains (Sflc) Measurement in Routine Laboratories. Unknown, Unknown, Unknown. Richmond, VIC, Australia: Wiley-Blackwell Publishing Asia.
2013
Journal Article
Evaluation of the N Latex free light chain assay in the diagnosis and monitoring of AL amyloidosis
Mollee, Peter, Tate, Jill and Pretorius, Carel J. (2013). Evaluation of the N Latex free light chain assay in the diagnosis and monitoring of AL amyloidosis. Clinical Chemistry and Laboratory Medicine, 51 (12), 2303-2310. doi: 10.1515/cclm-2013-0361
2013
Conference Publication
Rapid Molecular Diagnosis Of JAK2V617F Negative MPN By Targeted Deep Sequencing Using The Ion Torrent PGM
Klose, Nathan, Tallack, Michael R, Magor, Graham, Mollee, Peter and Perkins, Andrew C (2013). Rapid Molecular Diagnosis Of JAK2V617F Negative MPN By Targeted Deep Sequencing Using The Ion Torrent PGM. 55th ASH Annual Meeting, New Orleans, LA, 7-10 December 2013. American Society of Hematology. doi: 10.1182/blood.v122.21.4093.4093
2013
Conference Publication
Diagnosis of amyloidosis subtype by laser-capture microdissection (LCM) and tandem mass spectrometry (MS) proteomic analysis
Mollee, Peter, Renaut, Patricia, Boros, Samuel, Loo, Dorothy and Hill, Michelle (2013). Diagnosis of amyloidosis subtype by laser-capture microdissection (LCM) and tandem mass spectrometry (MS) proteomic analysis. 55th ASH Annual Meeting, New Orleans, LA United States, 7-10 December 2013. Washington, DC United States: American Society of Hematology. doi: 10.1182/blood.v122.21.5295.5295
2013
Conference Publication
Diagnosis Of Amyloidosis Subtype By Laser-Capture Microdissection (LCM) and Tandem Mass Spectrometry (MS) Proteomic Analysis
Mollee, Peter, Renaut, Patricia, Boros, Samuel, Loo, Dorothy and Hill, Michelle (2013). Diagnosis Of Amyloidosis Subtype By Laser-Capture Microdissection (LCM) and Tandem Mass Spectrometry (MS) Proteomic Analysis. 55th Annual Meeting of the American-Society-of-Hematology, New Orleans La, Dec 07-10, 2013. WASHINGTON: AMER SOC HEMATOLOGY.
2013
Conference Publication
Serum levels Of CD178 (Soluble FasL) predict treatment response and survival in chronic lymphocytic leukaemia (CLL)
Mollee, Peter, Burgess, Melinda, McMillan, Nigel, Saunders, Nicholas, Cheung, Catherine, Hallek, Michael and Gill, Devinder S (2013). Serum levels Of CD178 (Soluble FasL) predict treatment response and survival in chronic lymphocytic leukaemia (CLL). 55th ASH Annual Meeting, New Orleans, LA, 7-10 December 2013. American Society of Hematology. doi: 10.1182/blood.v122.21.2866.2866
2013
Journal Article
Towards improved measurement of serum free light chains: clinical and laboratory issues
Tate, Jill and Mollee, Peter (2013). Towards improved measurement of serum free light chains: clinical and laboratory issues. Biochimica Clinica, 37 (5), 395-404.
Funding
Current funding
Past funding
Supervision
Availability
- Associate Professor Peter Mollee is:
- Available for supervision
Before you email them, read our advice on how to contact a supervisor.
Supervision history
Current supervision
-
Master Philosophy
Novel Radionuclide Tracers for Imaging in Amyloidosis
Principal Advisor
Other advisors: Associate Professor Colm Keane
-
Doctor Philosophy
Addressing frailty in older people with haematological malignancies
Associate Advisor
Other advisors: Associate Professor Emily Gordon, Dr Natasha Reid, Professor Ruth Hubbard
Media
Enquiries
For media enquiries about Associate Professor Peter Mollee's areas of expertise, story ideas and help finding experts, contact our Media team: